Chargement en cours...

The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma

Lenalidomide is an integral, yet evolving, part of current treatment pathways for both transplant-eligible and transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM). It is approved in combination with dexamethasone as first-line therapy for transplant-ineligible patients with N...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Hematol
Auteurs principaux: Merz, Maximilian, Dechow, Tobias, Scheytt, Mithun, Schmidt, Christian, Hackanson, Bjoern, Knop, Stefan
Format: Artigo
Langue:Inglês
Publié: Springer Berlin Heidelberg 2020
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340649/
https://ncbi.nlm.nih.gov/pubmed/32296915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04023-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!